Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 195.35

-0.8%

Dec 2 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Machaon who wrote (17955)	3/26/1998 10:35:00 PM
From: Henry Niman	Read Replies (1) of 32384

Bob, Thanks for quoting some of the more relevant portions of the press release. My earlier comments were based on a quick read. However, it does look like the initial scenario I posted is fairly likely. I suspect that the FDA viewed a delayed submission as a win/win situation. What is most important (for patients, LGND, and shareholders) is the final approval date. The FDA of course wants the best data that they can get. My guess is that they traded the final International data for an expedited review. Thus, the FDA would get the final data and LGND would get an early approval date. I suspect that the street can figure this out (after all, they have all night to read the article), and the news will be taken as a strong positive. As I said earlier, I'm not sure if the expected announcements will have a major effect on LGND's price, but they will pave the way for some rather dramatic moves on the subsequent reports.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next